Compositions and methods for alleviating depression or improving cognition

Details for Australian Patent Application No. 2009212065 (hide)

Owner Clera Inc.

Inventors Toleikis, Philip M.; Seeman, Philip

Agent Davies Collison Cave

Pub. Number AU-A-2009212065

PCT Pub. Number WO2009/097688

Priority 61/026,279 05.02.08 US

Filing date 5 February 2009

Wipo publication date 13 August 2009

International Classifications

A61K 31/4515 (2006.01) - having a butyrophenone group in position 1, e.g. haloperidol

A61K 31/00 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/097688 Priority application(s): WO2009/097688

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212072-Arylmethylidene heterocycles as novel analgesics

2009212026-Use of compounds extracted from Momordica charantia L. in the manufacture of medicaments for prevention and treatment of diabetes and obesity